Ruben Mesa

  • 18516 Citations
  • 63 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ruben Mesa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Primary Myelofibrosis Medicine & Life Sciences
Polycythemia Vera Medicine & Life Sciences
Essential Thrombocythemia Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Myeloproliferative Disorders Medicine & Life Sciences
Janus Kinase 2 Medicine & Life Sciences
Splenomegaly Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

Corrigendum to “Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib” [Leukemia Res. 79 (2019) 38–44] (Leukemia Research (2019) 79 (38–44), (S0145212619300384), (10.1016/j.leukres.2019.02.012))

Gerds, A. T., Tauchi, T., Ritchie, E., Deininger, M., Jamieson, C., Mesa, R., Heaney, M., Komatsu, N., Minami, H., Su, Y., Shaik, N., Zhang, X., DiRienzo, C., Zeremski, M., Chan, G. & Talpaz, M., Jan 1 2019, In : Leukemia Research.

Research output: Contribution to journalComment/debate

Primary Myelofibrosis

Development of a symptom assessment in patients with myelofibrosis: Qualitative study findings

Mesa, R., Su, Y., Woolfson, A., Prchal, J. T., Turnbull, K., Jabbour, E., Scherber, R., Shields, A. L., Krohe, M., Ojo, F., Pompilus, F., Cappelleri, J. C. & Harrison, C., Apr 11 2019, In : Health and Quality of Life Outcomes. 17, 1, 61.

Research output: Contribution to journalArticle

Open Access
Primary Myelofibrosis
Symptom Assessment

Facing erythrocytosis: Results of an international physician survey

Rumi, E., McMullin, M. F., Harrison, C., Ellis, M. H., Barzilai, M., Sarid, N., Mesa, R., Paoli, C., Angona, A., Sant'Antonio, E., Ferretti, V. V., Cavalloni, C., Casetti, I. C., Trotti, C. & Barbui, T., Jan 1 2019, In : American Journal of Hematology.

Research output: Contribution to journalLetter

Open Access
Surveys and Questionnaires

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis

Tamari, R., Rapaport, F., Zhang, N., McNamara, C., Kuykendall, A., Sallman, D. A., Komrokji, R., Arruda, A., Najfeld, V., Sandy, L., Medina, J., Litvin, R., Famulare, C. A., Patel, M. A., Maloy, M., Castro-Malaspina, H., Giralt, S. A., Weinberg, R. S., Mascarenhas, J. O., Mesa, R. & 6 othersRondelli, D., Dueck, A. C., Levine, R. L., Gupta, V., Hoffman, R. & Rampal, R. K., Jun 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 6, p. 1142-1151 10 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation

Online yoga in myeloproliferative neoplasm patients: Results of a randomized pilot trial to inform future research

Huberty, J., Eckert, R., Dueck, A., Kosiorek, H., Larkey, L., Gowin, K. & Mesa, R., Jun 7 2019, In : BMC Complementary and Alternative Medicine. 19, 1, 121.

Research output: Contribution to journalArticle

Open Access
Tumor Necrosis Factor-alpha


MATCH REPORT: FC Barcelona v RC Recreativo: Reserves smiling again (3-1)

Ruben Mesa


1 item of media coverage

Press/Media: Press / Media

Lista de convocados ante el Cádiz C.F.

Ruben Mesa


1 item of media coverage

Press/Media: Press / Media